Stay up to date with our newsletter

Get in touch!

To explore career opportunities with Sai Life Sciences, share your CV here.

Lets start the conversation!

Sign up to our newsletter

Thank you!
We will be in touch shortly.

2021.12.23

Watch Dr. M. Damodharan from Sai Life Sciences presenting on the topic 'Regulatory Compliance through Instrument Integration and Scientific Data Management'

Watch Dr. M. Damodharan from Sai Life Sciences presenting on the topic 'Regulatory Compliance through Instrument Integration and Scientific Data Management'

Dr. M. Damodharan, Chief Quality Officer at Sai Life Sciences participated in a webinar, presenting on the topic Regulatory Compliance through Instrument Integration and Scientific Data Management, organized by the International Society for Pharmaceutical Engineering  (ISPE), India.

The webinar titled ‘Regulatory Compliance through Instrument Integration and Scientific Data Management’ is part of the ongoing ‘Pharma Best Practices Webinars’ initiative by ISPE where each webinar features leading subject matter experts covering critical, relevant topics in pharmaceutical manufacturing.

In this webinar, Dr. M. Damodharan presented on the industry-first solution deployed successfully and their benefits in handling instrument integration, data storage, and archival functions and heading towards the fully paperless lab.

Key regulatory requirements and expectations addressed in the presentation:

1. Effective instrument integration in real-time from all types of instruments and all types of file and data formats.

2. Secure storage of the raw data and processed data at the time they are produced,

3. Secure storage and archival of the data for both internal and external audit purposes SDMS- Scientific data management system is the potential solution beyond LIMS, ELN, CDS, and Manual data storage and archival.

As per ISPE, over 1300+ delegate registrations were recorded for this event, which was broadcast live by ISPE on YouTube.

Watch the full video

https://www.youtube.com/watch?v=WfHPriSFKXQ
Share article

More News

2026.03.10

AI-driven retrosynthesis integrated into Discovery Chemistry

Sai Life Sciences has entered into a collaboration with Chemical.AI, a technology company specialising in computer-aided synthesis design, to integrate an AI-driven retrosynthesis platform into its Discovery Chemistry workflows. The integration enables medicinal chemists to evaluate synthetic routes more rapidly and explore a broader set of feasible pathways during early-stage drug discovery. Retrosynthesis is a […]
Read more

2026.03.10

Structural Biology capabilities launched with X-Ray Crystallography

Sai Life Sciences has introduced integrated structural biology capabilities with the establishment of X-ray protein crystallography workflows to support structure-based drug discovery programs. The platform encompasses end-to-end protein engineering capabilities, including construct design, gene synthesis, and in-house recombinant protein expression and purification. These foundational steps enable generation of high-quality protein material suitable for structural and […]
Read more

2026.03.09

New Medicinal Chemistry block set for inauguration in Hyderabad

A new Medicinal Chemistry block, Unit VIII, is set for inauguration at IKP, Genome Valley, Hyderabad, expanding discovery capacity to meet growing program demand. The four-floor facility spans approximately 100,000 sq. ft. and is designed to support large, multi-disciplinary project teams. It accommodates more than 200 fume hoods and includes a tightly integrated analytical laboratory […]
Read more

2026.03.09

AI-enabled production and material planning platform implemented

Over the past several months, focused AI pilot initiatives have been conducted across operations to evaluate practical applications that strengthen execution. One such initiative is now live across the network: Optimus, an integrated AI-enabled production and material planning platform, implemented at the end of December 2025. Optimus consolidates capacity planning, equipment allocation, and material availability […]
Read more

2026.03.09

Commercial-scale Photo Flow Chemistry successfully executed in Bidar

Commercial-scale flow chemistry has been successfully executed at our API manufacturing site in Bidar for a late-phase program supporting a US-based innovator. This execution builds on prior investments in continuous processing infrastructure at the site, including a 3-litre photo flow reactor equipped with a monochromatic blue LED light source. The platform enables controlled photochemical transformations […]
Read more